Intercytex part of consortia awarded substantial funding to establish US Armed Forces Institute of Regenerative Medicine (AFIRM)
AFIRM will use regenerative medicine to develop new treatments for battlefield injuries
25-Apr-2008 -
Intercytex Group plc announced that it is part of consortia that have been selected to establish the United States' Armed Forces Institute of Regenerative Medicine (AFIRM), supported by a foundation grant from the US Government totalling $85 million. The purpose of AFIRM is to use the science of ...
flow
inflammation
pressure
+3